Jonathan Meyer

Nov 11, 2024 | hmpgloballearningnetwork.com | Jonathan Meyer

Videos Psych Congress Steering Committee Member Jonathan Meyer, MD, voluntary clinical professor of psychiatry at the University of California San Diego, discusses the challenges in managing schizophrenia, particularly focusing on the persistence of negative cognitive symptoms despite current antipsychotic treatments.

Jul 22, 2024 | psychiatrictimes.com | Jonathan Meyer

CATEGORY 1 CMEPremiere Date: July 20, 2024Expiration Date: January 20, 2026This activity offers CE credits for:1. Physicians (CME)2. OtherAll other clinicians either will receive a CME Attendance Certificate or may choose any of the types of CE credit being offered. ACTIVITY GOALThe purpose of this activity is to review management of several clozapine-related adverse effects and outline considerations when addressing inadequate positive symptom response to clozapine. LEARNING OBJECTIVES1.

Jun 20, 2024 | psychiatrictimes.com | Jonathan Meyer

Premiere Date: June 20, 2024Expiration Date: December 20, 2025This activity offers CE credits for:1. Physicians (CME)2. OtherAll other clinicians either will receive a CME Attendance Certificate or may choose any of the types of CE credit being offered. ACTIVITY GOALTo discuss methods for optimizing clozapine treatment with a focus on evidence-based use of plasma levels. LEARNING OBJECTIVES1.

May 6, 2024 | psychiatrictimes.com | Jonathan Meyer |John J. Miller

May 6, 2024Jonathan M. Meyer, MD, sat down with Psychiatric Times' Editor-in-Chief at the 2024 APA Annual Meeting. CONFERENCE REPORTERPsychiatric Times Editor-in-Chief, John J. Miller, MD, sat down with Jonathan M. Meyer, MD, who he considers a mentor and a friend, at the 2024 American Psychiatric (APA) Annual Meeting to discuss lithium. Meyer presented on this treatment option in the session, "Reviving Lithium: An Undervalued Gem in Psychiatry."Miller considers Meyer's book with Stephen M.

Aug 7, 2023 | psychiatrist.com | Leslie Citrome |Jonathan Meyer

AbstractSchizophrenia is a chronic and debilitating mental health condition that significantly impacts quality of life and can shorten patients’ lifetime by decades. It is characterized by symptoms including hallucinations and delusions, apathy, and cognitive impairment, and people with schizophrenia also experience many somatic comorbidities, such as metabolic disturbances, infectious diseases, cardiovascular issues, and respiratory illnesses.